Abrilumab

BIOLOGICAL2 trials

Sponsors

Amgen

Conditions

Crohn's DiseaseUlcerative Colitis

Phase 2

Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis

CompletedNCT01694485

AmgenUlcerative Colitis

Start: 2012-11-16End: 2018-04-10Updated: 2019-06-27

Abrilumab (AMG 181) in Adults With Moderate to Severe Crohn's Disease

CompletedNCT01696396

AmgenCrohn's Disease

Start: 2012-12-04End: 2018-04-10Updated: 2019-06-27

Related Papers

Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis.

2018-11-2364 citations